1. Canada Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Microbix Biosystems Inc.

Microbix Biosystems Inc.

MBXBF
Microbix Biosystems Inc.US flagOther OTC
0.22
USD
- -
- -
29.70MMarket Cap

Total Valuation

Microbix Biosystems Inc. carries a market capitalization of 29.70M, placing it among publicly traded companies globally. Its enterprise value stands at 32.02M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap29.70M
Enterprise Value32.02M

Share Statistics

Microbix Biosystems Inc. currently has 137.76M shares outstanding.

Shares Outstanding137.76M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 2.25, and the price-to-book ratio stands at 2.86.

PE RatioN/A
PS Ratio2.25
PB Ratio2.86
P/TBV Ratio1.54
P/FCF Ratio-8.32
P/OCF Ratio-7.02

Enterprise Valuation

On an enterprise value basis, Microbix Biosystems Inc. trades at an EV/EBITDA multiple of 14.71 and an EV/FCF ratio of 14.98. The EV/Sales ratio of 2.16 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 47.95 provides insight into valuation relative to core operating earnings.

EV / Sales2.16
EV / EBITDA14.71
EV / EBIT47.95
EV / FCF14.98

Financial Position

Microbix Biosystems Inc. maintains a current ratio of 5.35, meaning it holds 5.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 27.03, indicating elevated leverage, while an interest coverage ratio of -3.19 demonstrates limited ability to service its debt obligations.

Current Ratio5.35
Quick Ratio2.77
Debt / Equity27.03
Debt / EBITDA-2.18
Interest Coverage-3.19

Financial Efficiency

Return on Equity (ROE)-37.97
Return on Assets (ROA)-15.31
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover0.93

Stock Price Statistics

Microbix Biosystems Inc.'s stock has declined approximately -4.91702% over the past 52 weeks. The 50-day moving average sits at 0.19, while the 200-day moving average is 0.18.

Beta (5Y)N/A
52-Week Price Change-4.91702%
50-Day Moving Average0.19
200-Day Moving Average0.18
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Microbix Biosystems Inc. generated 14.81M in revenue and converted that into -5.72M in net income, yielding earnings per share of -0.04. EBITDA reached -3.11M, while operating income came in at -4.95M.

Revenue14.81M
Gross Profit6.29M
Operating Income-4.95M
Pretax Income-5.78M
Net Income-5.72M
EBITDA-3.11M
EBIT-4.95M
Earnings Per Share (EPS)-0.04

Balance Sheet

Microbix Biosystems Inc. holds 8.13M in cash and equivalents against 6.80M in total debt, resulting in a net debt position of -2.75M. Total book value stands at 11.66M, with working capital of 17.93M providing operational flexibility.

Cash & Cash Equivalents8.13M
Total Debt6.80M
Net Debt-2.75M
Equity (Book Value)11.66M
Book Value Per Share0.08
Working Capital17.93M

Cash Flow

Microbix Biosystems Inc. produced -4.75M in operating cash flow over the past twelve months. After subtracting -741,955.00 in capital expenditures, free cash flow totaled -5.49M - equivalent to -0.04 per share.

Operating Cash Flow-4.75M
Capital Expenditures-741,955.00
Free Cash Flow-5.49M
FCF Per Share-0.04

Margins

Microbix Biosystems Inc. operates with a gross margin of 42.49, reflecting its pricing power and cost economics. The operating margin of -33.40 and net profit margin of -38.62 provide insight into operational efficiency.

Gross Margin42.49
Operating Margin-33.40
Pretax Margin-39.00
Profit Margin-38.62
EBITDA Margin-21.01

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield2.75
FCF Yield-12.01

Scores

Microbix Biosystems Inc. posts an Altman Z-Score of 0.91, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score0.91